戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cteriostatic and does not kill drug-tolerant persisters.
2  detection distinguished ADHD remitters from persisters.
3      Hydrolyzing corrupted tRNA resuscitates persisters.
4 al component TolC, show higher expression in persisters.
5 les in S. aureus did not affect the level of persisters.
6 illin-resistant Staphylococcus aureus (MRSA) persisters.
7 y a small population of dormant cells called persisters.
8 ultures, a finding that is characteristic of persisters.
9 e the activity of quinolones against E. coli persisters.
10 ght be due to the existence of drug-tolerant persisters.
11 ssociated proteins were unique for ofloxacin persisters.
12 ignificantly higher in resolvers compared to persisters.
13 ic inheritance causes increased frequency of persisters.
14 ess the most therapeutic potential to combat persisters.
15 rrupting a target in dormant cells will kill persisters.
16 que stress response signature: these are the persisters.
17 pically resistant cells, the latter known as persisters.
18 sence of biofilms and metabolically inactive persisters.
19 nts and young adults with childhood ADHD (87 persisters, 23 remitters) and 169 age-matched control pa
20 induces the formation of both VBNC cells and persisters, a finding not previously described for eithe
21 antibiotic tolerance is related to bacterial persisters, a sub-population of bacteria phenotypically
22 ormation of Mycobacterium tuberculosis (Mtb) persisters achieves a high level of antibiotic-tolerance
23 le has no effect on the formation of E. coli persisters against an aminocoumarin, novobiocin, which t
24 stimulates the formation of Escherichia coli persisters against quinolone antibiotics which target th
25 le to eradicate MRSA biofilms or non-biofilm persisters alongside 14.
26 rge these two fields of research: antibiotic persisters and host-pathogen interactions.
27 tment is not effective against infections by persisters and MDR-Mtb, novel therapeutics are needed.
28 ways, whereas ClpA was unique for ampicillin persisters and nucleoid-associated proteins were unique
29 y of network structures were compared across persisters and remitters using a permutation test.
30 nce-monitoring task distinguish between ADHD persisters and remitters.
31 s have an important role in the formation of persisters and several studies show that they can form i
32 n the basis for translational suppression in persisters and suggest how persisters survive exposure t
33 ngs show that fluoroquinolones damage DNA in persisters and that the ensuing SOS response accelerates
34                 ADHD remitters differed from persisters and were indistinguishable from control parti
35 ericidal, killed drug-tolerant mycobacterial persisters, and rapidly cleared M. tuberculosis infectio
36 r formation of both ampicillin and ofloxacin persisters, and we demonstrated that higher synthesis of
37                                              Persisters are a sub-population of genetically sensitive
38                                    Bacterial persisters are able to tolerate high levels of antibioti
39                                         Rare persisters are already present in naive T-ALL population
40 ntified as contributing to the production of persisters are analogous to the so-called mutator genes;
41                                    Bacterial persisters are antibiotic-tolerant cells, but little is
42                                              Persisters are associated with chronic infections and an
43                                              Persisters are dormant phenotypic variants of bacterial
44                                              Persisters are in a dormant metabolic state, even while
45                                              Persisters are metabolically dormant, so they are highly
46                                              Persisters are multidrug-tolerant bacteria that could ac
47                                              Persisters are nongrowing, transiently antibiotic-tolera
48 are, phenotypically resistant subpopulation, persisters are notoriously hard to study and define.
49                                              Persisters are phenotypic variants of normal cells and p
50                                              Persisters are phenotypic variants of regular cells that
51                                              Persisters are phenotypic variants present within isogen
52                                    Bacterial persisters are phenotypic variants that form from the ac
53                 Here, we show that S. aureus persisters are produced due to a stochastic entrance int
54                                    Bacterial persisters are rare phenotypic variants that temporarily
55                                    Bacterial persisters are rare, phenotypically distinct cells that
56     Using computerized tracking we show that persisters are small at birth and slowly replicating.
57                                    Bacterial persisters are thought to underlie the relapse of chroni
58                                 We find that persisters are unlikely to derive from bacteria with low
59 ic and pharmacogenomic screens revealed that persisters are vulnerable to inhibition of the transcrip
60  cells in many bacterial populations, called persisters, are much less sensitive to antibiotic treatm
61 more, this antibiotic eliminated challenging persisters as well as established biofilms.
62 rmant bacteria at pH 5.8, and nonreplicating persisters at low oxygen tension of </= 10 parts per bil
63 s (MRSA), including replicating, biofilm and persister bacterial cells, and also disperses biofilm bi
64 counts 3-4 weeks into therapy may identify a persister bacterial phenotype.
65         This subpopulation was distinct from persisters, became predominant in colistin, returned to
66 e, these findings raise the possibility that persisters behave as an evolutionary reservoir from whic
67 resistance mechanisms that can expand from a persister bottleneck is unknown.
68     Several approaches were proposed to kill persisters by altering their metabolism, obviating the n
69 omes a fairly nonspecific protease and kills persisters by degrading over 400 proteins, forcing cells
70                                        These persisters can be visualized using dual-reporter mycobac
71                                    Microbial persisters can cause recurrent or intractable infections
72 dent growth arrest, explaining how bacterial persisters can resume growth.
73 ls and provide new insight into a potential "persister cancer cell" phenotype.
74  stress, reduces colonization and attenuates persister cell and biofilm formation, suggesting that me
75   Loss of GPX4 function results in selective persister cell ferroptotic death in vitro and prevents t
76 orm studies on the role of the Psp system in persister cell formation and cell envelope protection in
77                      This prevention of both persister cell formation and drug resistance leads ultim
78 in and repressing stress responses to reduce persister cell formation by 21-fold.
79 of ppGpp so that the underlying mechanism of persister cell formation could be explored.
80 PI-7 expressed genes related to dormancy and persister cell formation during the late decay phase, wh
81 T, indicating that multiple pathways lead to persister cell formation in C. crescentus.
82  characterized to participate in biofilm and persister cell formation in Escherichia coli.
83                 Production of YafQ increased persister cell formation with multiple antibiotics, and
84 nonstringent processes, including virulence, persister cell formation, and biofilm production.
85 ese TAS, which are classically implicated in persister cell formation, are also induced during incuba
86 s have been postulated to be responsible for persister cell formation, we investigated the influence
87  the YafQ/DinJ Escherichia coli TA system on persister cell formation.
88 uch as phage inhibition, gene regulation and persister cell formation.
89 e TA system has only a minor contribution to persister cell formation.
90 t potent biofilm-eradicating agent (>/=99.9% persister cell killing) against MRSA (MBEC < 10 muM), MR
91                                          The persister cell pool constitutes a reservoir from which d
92 indings quantify pre-existing resistance and persister cell populations, which are essential for the
93 ds directly for stimulating Escherichia coli persister cell resuscitation, we identified that 2-{[2-(
94 nd are recognized by macrophages, while in a persister cell status, and upon awakening due to exposur
95 tants from GM-CSF treated P. aeruginosa PAO1 persister cell suspensions were found cidal to the pyoci
96            Consequently, we demonstrate that persister cells acquire a dependency on GPX4.
97             Relative to GSI-sensitive cells, persister cells activate distinct signaling and transcri
98 bitors effectively inhibits the emergence of persister cells and may represent a new therapeutic stra
99                                              Persister cells are a multi-drug tolerant subpopulation
100              In contrast, awakened S. aureus persister cells are able to initiate infections in A. th
101                                    Bacterial persister cells are highly tolerant to antibiotics and c
102              Our results show that S. aureus persister cells are not able to initiate infections in A
103                                 Tolerant and persister cells are thought to underlie biofilm-related
104 he role of FGFR in promoting the survival of persister cells been elucidated.
105 or HipA-mediated antibiotic persistence, but persister cells can form in the absence of all hipBA ope
106                   Translation remodelling in persister cells coincides with an increased N6-methylade
107 istant cell state underlies the behaviour of persister cells derived from a wide range of cancers and
108 mmunities of enriched populations containing persister cells encased within a protective extracellula
109 ibit quiescence and reduce the population of persister cells formed by the uropathogenic strain, CFT0
110  between therapy failure and the presence of persister cells has started to emerge.
111  factors (in the absence of immune cells) on persister cells have not been studied.
112 ysical and molecular relatedness of VBNC and persister cells in a standardized model organism.
113 suggested to play a part in the formation of persister cells in mycobacteria.
114 M), as well as the effective killing of MRSA persister cells in non-biofilm cultures.
115 e investigated whether Staphylococcus aureus persister cells initiate an infection and are recognized
116  and found that the immune clearance rate of persister cells is a key feature.
117 The most differentially up-regulated gene in persister cells is mqsR, a gene that, with the antitoxin
118 timulating factor (GM-CSF) can sensitize the persister cells of Pseudomonas aeruginosa PAO1 and PDO30
119 nthesis via Ras can lead to formation of AmB-persister cells regardless of whether the cells are in p
120 cal strategy for preventing the emergence of persister cells remains elusive.
121                                    Bacterial persister cells represent a subpopulation of cells that
122                                       Hence, persister cells resuscitate via activation of RluD.
123                                We found that persister cells still form, although at lower levels, in
124                                              Persister cells survive antibiotic and other environment
125                                      Dormant persister cells that are tolerant to killing by antibiot
126                                    Targeting persister cells therefore presents a therapeutic opportu
127 nti-cancer drug mitomycin C (MMC) eradicates persister cells through a growth-independent mechanism.
128 eract, leading to enhanced susceptibility of persister cells to antibiotics.
129           Furthermore, exposure of S. aureus persister cells to cis-DA led to a loss of tolerance to
130 that stimulates Mtb respiration and converts persister cells to metabolically active cells.
131                                       Cancer persister cells tolerate anticancer drugs and serve as t
132 y, including genomic stability, formation of persister cells under antibiotic stress, and resistance
133 acteremia was considered, the growth rate of persister cells was also found to be a key feature.
134        In addition, macrophage engulfment of persister cells was significantly lower than engulfment
135               Persistent bacteria, including persister cells within surface-attached biofilms and slo
136                                              Persister cells, a tolerant cell sub-population, are com
137  role of efflux pumps and the development of persister cells, are the topics of the final article by
138 s and induces growth arrest and apoptosis in persister cells, at doses well tolerated by GSI-sensitiv
139 gellar motility and pyocin production in the persister cells, but not the normal cells of P. aerugino
140 oad-spectrum compound capable of eliminating persister cells, meriting investigation as a new approac
141 iated with initially surviving drug-tolerant persister cells, which can seed bona fide genetic mechan
142 siology, and contribute to the occurrence of persister cells.
143  increased the number of active ribosomes in persister cells.
144  death and production of antibiotic-tolerant persister cells.
145 gy to rapidly purify ribosome complexes from persister cells.
146 ce for the clinical significance of VBNC and persister cells.
147 osomal RNA and protein components from these persister cells.
148 ively increased translation and is lethal to persister cells.
149 tibiotics against Burkholderia thailandensis persister cells.
150  T-ALL resistance, identifying GSI-tolerant 'persister' cells that expand in the absence of NOTCH1 si
151  underlying the survival of residual cancer 'persister' cells.
152 es error-prone polymerases in drug-tolerant (persister) cells.
153                            All bacteria form persisters, cells that are multidrug tolerant and theref
154 sis (Mtb) cells, but the remaining cells are persisters, cells with decreased metabolic rate, refract
155 of this phenomenon, as well as to assess the persisters' clinical relevance.
156 ouble-hit lymphoma evolves from outgrowth of persister clones displaying loss of 18q21 amplicons that
157 ndant, making it challenging to develop anti-persister compounds.
158 er, populations derived from fluoroquinolone persisters contain significantly greater quantities of a
159 her with the invention of new tools to study persisters, could have important implications for the de
160                              Here we compare persister-derived, erlotinib-resistant colonies that aro
161 th otherwise lethal drugs, the drug-tolerant persisters (DTPs), exhibit a repressed chromatin state c
162  rise to small populations of "drug tolerant persisters" (DTPs) (Figure 1B-C) that were reversed duri
163 ug-sensitive cells, so-called drug-tolerant "persisters" (DTPs), can survive cytotoxic drug exposure
164  single-cell analysis to identify Salmonella persisters during infection.
165 , so too does the need for clinically useful persister-eradication strategies.
166 l model of resistance development, including persister evolution and preexisting resistance, solely b
167                                Assuming only persister evolution would require very high mutation ind
168  of only preexisting resistant cells or only persister evolution, it is not possible to explain the o
169  Interestingly, the lag time distribution of persisters exhibited a long tail captured by a power-law
170 with MDD are related to longitudinal course: persisters exhibited a more densely connected network at
171 eveloped, adopting the notion that bacterial persisters exist in the biofilms together with regulator
172       Our results show that (i) ribosomes in persisters exist largely as inactive ribosomal subunits,
173                                        Since Persister-FACSeq can be applied to study persistence to
174               As a proof-of-concept, we used Persister-FACSeq on a library of reporters to study gene
175                            Here we developed Persister-FACSeq, which is a method that uses fluorescen
176  following ofloxacin treatment, we find that persisters filament extensively and induce impressive SO
177                                     Although persisters form during normal growth from native stresse
178 e we show that wild-type HipA contributes to persister formation and that high-persister hipA mutants
179 trant infections, the mechanisms that induce persister formation are not fully understood.
180 ort that Samonella toxin TacT contributes to persister formation by acetylating tRNA, a novel mechani
181 e exhibits qualitatively similar behavior to persister formation for short dosing times, and similar
182                                              Persister formation has been attributed to alterations i
183 is study, we find that salicylate can induce persister formation in Escherichia coli via generation o
184                             The mechanism of persister formation in Gram-positive bacteria is unknown
185 and found that a persister killer, but not a persister formation inhibitor, could provide for an effe
186  pathways leading to growth mode-independent persister formation is important for developing novel st
187 del, we have reconstructed a molecular-level persister formation pathway from initial stress (glucose
188 entify the shared and unique elements of the persister formation pathways.
189 ynamics by considering adaptive response and persister formation separately.
190  that loss of clpA, ssrA, or smpB eliminated persister formation through relaxation of the stringent
191  toxin-antitoxin modules have been linked to persister formation(4-6).
192 t over-expressed HipA protein, which induces persister formation, and were treated with ampicillin to
193 n antibiotic's mode of action when analyzing persister formation, demonstrate that individual stresse
194 ong multiple biological pathways involved in persister formation, indicates that persisters implement
195 intimately linked to bacterial pathogenesis, persister formation, stress responses, and ribosome inte
196 d antibiotics together effectively attenuate persister formation, suggesting a combination strategy t
197 ial and metabolism, may play a broad role in persister formation.
198 thereby inhibiting translation and promoting persister formation.
199 titoxin modules contributed to intracellular persister formation.
200 iverse signalling roles, including a role in persister formation.
201 as a prime target for reducing the number of persisters formed in nutrient-depleted, non-growing popu
202 ters into metabolic quiescence (dormancy) as persister forms.
203 at show a characteristic correlation between persister frequency and the number of toxin-antitoxin sy
204 erexpression of these toxins often increases persister frequency in a defined population.
205                             The emergence of persisters from dormancy after antibiotic withdrawal lea
206                              Biofilms shield persisters from the immune system, suggesting that an an
207                                 Accordingly, persister GSCs upregulate, and are dependent on, the his
208                             For a long time, persisters have been assumed to be nonreplicating dorman
209                             While antibiotic persisters have been extensively studied over the last d
210                                              Persisters have been hypothesized to underlie the recalc
211                                              Persisters have traditionally been thought of as metabol
212  such knowledge has remained elusive because persisters have yet to be segregated from other cell typ
213 nstrate that individual stresses can produce persister heterogeneity, and emphasize the importance of
214 ributes to persister formation and that high-persister hipA mutants cause multidrug tolerance in urin
215 olved in persister formation, indicates that persisters implement a positive defense against antibiot
216 h rapamycin also increased the proportion of persisters in Candida albicans and Candida glabrata.
217 ary phase metabolism in generation of type I persisters in Escherichia coli, which are those that are
218 s stimulate the formation of fluoroquinolone persisters in Escherichia coli.
219                Due to the low frequencies of persisters in growing bacterial cultures and the complex
220 tence, report evidence for the importance of persisters in infection, and highlight studies that brid
221 t bactericide for a broad range of bacterial persisters, including commensal Escherichia coli K-12 as
222    We show that the stimulation of quinolone persisters is due to indole pulse, rather than persisten
223 monstrate that VBNC cells are present during persister isolation experiments, further indicating that
224 nt and relapsing bacteremia and found that a persister killer, but not a persister formation inhibito
225  respiration during stationary phase reduces persister levels by up to approximately 1,000-fold.
226 e, we adapted a biofilm culture to model Mtb persister-like bacilli (PLB) and demonstrated that PLB u
227                                              Persister-like cells and genomic amplifications of IRS2
228         In this Review, we discuss protozoan persister-like cells that have been linked to persistent
229 ory to drug treatment, which we refer to as 'persister-like cells'.
230 ggest that host immune factors and bacterial persisters may directly interact, leading to enhanced su
231  the underlying conclusion that adaptive and persister mechanism provide protection for different cha
232 or relA, implicated in the regulation of the persister metabolic state.
233        WR12 and D-IK8 were able to eradicate persisters, MRSA in stationary growth phase, and showed
234 understand the pathogen-host interactions of persister MRSAs in vivo.
235              We also determine that the high-persister mutant strain of Escherichia coli, HipQ, is as
236                           Perplexingly, high-persister mutations map to the N-subdomain-1 of HipA far
237                                              Persisters (n = 253) had a higher baseline IDS sum score
238  had the largest difference in importance in persisters' network compared with that of remitters (Coh
239 amage, which has led to the supposition that persister offspring give rise to antibiotic-resistant mu
240 ne function have the potential to eradicate "persister" organisms and delay the emergence of resistan
241 icated that formation and maintenance of the persister phenotype are regulated by suppressing transla
242 lipid bodies has been proposed to identify a persister phenotype of Mycobacterium tuberculosis cells.
243   The ras1, ras2 and tor1 mutants had a high-persister phenotype similar to wild-type biofilm and pla
244 of barcoded lineages adopt a Notch-dependent persister phenotype that sustains them through early dru
245 nd next generation sequencing to interrogate persister physiology and its heterogeneity.
246                                 Knowledge of persister physiology would illuminate avenues for therap
247 n resulted in a significant depletion of the persister population in response to various classes of a
248 rvival was constrained to a slow-replicating persister population of S. Typhimurium induced within th
249            Isoniazid induced a drug-tolerant persister population only when necrotic lesions were pre
250 rvival, one possible hypothesis is that this persister population requires the glucose redirected to
251  tumor cell population versus a slow-growing persister population that is the precursor of acquired T
252 r findings indicate that upon awakening of a persister population the cells regain their ability to i
253 ulted in the most efficient reduction in the persister population.
254 wever, combining preexisting resistance with persister populations can explain the observed tumor vol
255 sis drugs that are active against dormant or persister populations of Mycobacterium tuberculosis.
256 who progressed on EGFR TKI as surrogates for persister populations, we performed whole-genome CRISPR
257 gradient on the recovery of B. thailandensis persister populations.
258 d the 11th module, hipBA, encodes HipA (high persister protein A) kinase, which inhibits glutamyl tRN
259 model reveals the crucial role played by the persisters, quorum sensing molecules, and growth factors
260 at diauxie-dependent formation of ampicillin persisters required RelA and that loss of clpA, ssrA, or
261                       Here, modeling of BETi-persister/resistance (BETi-P/R) in human postmyeloprolif
262                                  Eventually, persisters resume growth, accounting for relapses of inf
263                                         Some persisters resumed intracellular growth after phagocytos
264  RNA RybB which represses rluD led to faster persister resuscitation.
265            In particular, a sub-group termed persisters show high tolerance to antibiotics.
266 sly produces metastable phenotypic variants (persisters), some of which represent stem-like states th
267                      Thus, the drug-tolerant persister state does not limit--and may even provide a l
268 ular metabolite that has been linked to this persister state is guanosine tetraphosphate (ppGpp), the
269 h are often linked to cell growth, promote a persister state regardless of the underlying physiologic
270 trong selective drug pressure by entering a 'persister' state of negligible growth.
271                                     Further, persister status is generated via adaptive super-enhance
272 cal and simulation results probe the optimal persister strategy, revealing results that are consisten
273             Previous studies have found that persisters survive antibiotic treatment by maintaining a
274 al suppression in persisters and suggest how persisters survive exposure to multiple antibiotics.
275  a subpopulation of bacterial cells known as persisters survives by halting metabolism.
276 f cells is killed but a subpopulation called persisters survives the treatment.
277 pH induced nonstable SCVs and nonreplicating persisters that are capable of regrowth.
278 ment is thought to be due to the presence of persisters that are non-growing, antibiotic-insensitive
279 plication or the formation of nonreplicating persisters that could provide a reservoir for relapsing
280 ed subpopulation of reversibly drug-tolerant persisters that is dynamically maintained within a wide
281  of stresses in the host and form nongrowing persisters that survive both antibiotics and host immune
282 pulation of growing and nongrowing cells, or persisters, that exist under normal conditions, rather t
283  the Salmonella population forms non-growing persisters through the action of toxin-antitoxin modules
284 L-arginine and gentamicin against planktonic persisters through time-kill curves of late stationary-p
285 hesis of the alarmone was needed to increase persisters to ampicillin compared to ofloxacin.
286                         Here, we examine how persisters to ampicillin form from the same metabolic st
287 osynthesis, as evidenced by the formation of persisters to antibiotics that target enzymes in differe
288 echanistic pathway by which Escherichia coli persisters to ofloxacin form in response to a carbon sou
289 acterial stress response pathways that allow persisters to survive many harsh conditions, including a
290                               The ability of persisters to survive their interaction with a host is i
291 vest in a slow-growing subpopulation, called persisters, to ensure survival in the face of uncertaint
292                                              Persister tolerance is generally attributed to minimally
293 due to subpopulation of persistent bacteria (persisters) tolerant to high concentrations of antibioti
294                               Drug-tolerant "persister" tumor cells underlie emergence of drug-resist
295           Here we demonstrate that bacterial persisters, under beta-lactam antibiotic treatment, show
296 dentified chromatin regulators essential for persister viability, including BRD4.
297 f azlocillin and cefotaxime on drug-tolerant persisters were done by semisolid plating method.
298                                         ADHD persisters were impaired compared with controls on all c
299 creased prevalence of dormant cells known as persisters, which are characterized by an up-regulation
300 clude phenotypically dormant cells, known as persisters, which are tolerant to many antibiotics and o

 
Page Top